Orchestra Biomed Holdings, Inc. (OBIO)
4.45
+0.15
(+3.49%)
USD |
NASDAQ |
Dec 16, 16:00
4.45
0.00 (0.00%)
After-Hours: 17:35
Orchestra Biomed Holdings Profit Margin (Quarterly): -2.42K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Ligand Pharmaceuticals, Inc. | -- |
| Clearside Biomedical, Inc. | -2.97K% |
| Zymeworks, Inc. | -70.99% |
| CEL-SCI Corp. | -- |
| AIM ImmunoTech, Inc. | -12.63K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -268.1% |
| Return on Assets | -104.8% |
| Return on Invested Capital | -168.1% |
| Gross Profit Margin (Quarterly) | 84.90% |
| Operating Margin (Quarterly) | -2.36K% |
| Return on Net Operating Assets | -2.11K% |